Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
15hon MSN
Kimberly-Clark Snaps Up Tylenol Maker Kenvue in £30 Billion Takeover Amid Autism Controversy
A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...
The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...
IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ ...
Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...
Former Vice President Dick Cheney has died at age 84. And, today, voters in New York, Virginia and New Jersey choose new ...
Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...
It pays a semiannual dividend and yields 4.4% based on the two most recent payments. Morningstar Equity analysts note that the firm pays out roughly 50% of its earnings as dividends, which is about ...
One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...
The consumer health and wellness giants are both Dividend Kings, with more than 50 years of consecutive annual payout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results